These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2867369)

  • 1. HTLV-III antibody positivity in Zambian copper belt.
    Buchanan DJ; Downing RG; Tedder RS
    Lancet; 1986 Jan; 1(8473):155. PubMed ID: 2867369
    [No Abstract]   [Full Text] [Related]  

  • 2. HTLV-III serology distinguishes atypical and endemic Kaposi's sarcoma in Africa.
    Bayley AC; Downing RG; Cheingsong-Popov R; Tedder RS; Dalgleish AG; Weiss RA
    Lancet; 1985 Feb; 1(8425):359-61. PubMed ID: 2857417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III antibody in East Africa.
    N Engl J Med; 1986 Jul; 315(4):259-60. PubMed ID: 3014335
    [No Abstract]   [Full Text] [Related]  

  • 4. HTLV-III infection in the RSA.
    Becker WB
    S Afr Med J; 1986 Oct; Suppl():26-7. PubMed ID: 3535115
    [No Abstract]   [Full Text] [Related]  

  • 5. [Features of the acquired immunodeficiency syndrome in 93 patients at the Instituto Nacional de la Nutrición "Salvador Zubirán"].
    Ruiz-Palacios GM; Ponce de León S; Cruz López A; Tinoco JC; Schnieders B; Macías A; Ortiz E; Valpuesta V; Nares F
    Rev Invest Clin; 1987; 39 Suppl():7-12. PubMed ID: 3482720
    [No Abstract]   [Full Text] [Related]  

  • 6. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.
    Marquart KH; Müller HA; Hartter P; Oku JC; Ayuko WO
    J Trop Med Hyg; 1987 Apr; 90(2):93-4. PubMed ID: 3470530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-III antibody in drug abusers in the west of Scotland: the Edinburgh connection.
    Follett EA; McIntyre A; O'Donnell B; Clements GB; Desselberger U
    Lancet; 1986 Feb; 1(8478):446-7. PubMed ID: 2868365
    [No Abstract]   [Full Text] [Related]  

  • 9. Voluntary deferral of blood donations and HTLV-III antibody positivity.
    Kalish RI; Cable RG; Roberts SC
    N Engl J Med; 1986 Apr; 314(17):1115-6. PubMed ID: 3457266
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of HTLV-III/LAV antibodies among Haitians.
    Pitchenik AE; Spira TJ; Elie R; Fischl MA; Getchell JP; Arnoux E; Pierre GD; Laroche AC; Guerin JM; Malebranche R
    N Engl J Med; 1985 Jun; 312(26):1705-6. PubMed ID: 3858670
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France.
    Allain JP
    N Engl J Med; 1986 Aug; 315(8):517-8. PubMed ID: 3016541
    [No Abstract]   [Full Text] [Related]  

  • 12. LAV/HTLV-III seroconversion and disease in hemophiliacs treated in France.
    Mathez D; Leibovitch J; Sultan Y; Maisonneuve P
    N Engl J Med; 1986 Jan; 314(2):118-9. PubMed ID: 3079879
    [No Abstract]   [Full Text] [Related]  

  • 13. Lack of evidence of HTLV-III endemicity in southern Africa.
    Lyons SF; Schoub BD; McGillivray GM; Sher R; Dos Santos L
    N Engl J Med; 1985 May; 312(19):1257-8. PubMed ID: 2985989
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 15. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia.
    Melbye M; Njelesani EK; Bayley A; Mukelabai K; Manuwele JK; Bowa FJ; Clayden SA; Levin A; Blattner WA; Weiss RA
    Lancet; 1986 Nov; 2(8516):1113-5. PubMed ID: 2877269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African Kaposi's sarcoma and AIDS.
    Downing RG; Eglin RP; Bayley AC
    Lancet; 1984 Mar; 1(8375):478-80. PubMed ID: 6142209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for human infection with an HTLV III/LAV-like virus in Central Africa, 1959.
    Nahmias AJ; Weiss J; Yao X; Lee F; Kodsi R; Schanfield M; Matthews T; Bolognesi D; Durack D; Motulsky A
    Lancet; 1986 May; 1(8492):1279-80. PubMed ID: 2872424
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of correlation between promiscuity and seropositivity to HTLV-III from a low-incidence area for AIDS.
    Calabrese LH; Proffitt MR; Rehm S; Lederman M; Carey JT; Houser HB; Edmonds K; Ellner JJ
    N Engl J Med; 1985 May; 312(19):1256-7. PubMed ID: 2985988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.